Back

Boosting secondary prevention: efficacy and adherence of inclisiran in post-acute coronary syndrome very high-risk patients

3 April 2025 (08:00 - 19:00)
Organised by: Logo
Congress Presentation Part of: Supporting adherence: status quo and best practice Treatment EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Sara Sposini Ghezzi

Marsciano (Italy)

4 More presentations in this session

Presentation thumbnail
Patient characteristics and discontinuation patterns amongst renin-angiotensin system inhibitor users in the United Kingdom: analysis using a national primary care database
Miss Y. Yu (London, GB)
Abstract Slides
Presentation thumbnail
Structured pharmaceutical interviews enhance knowledge and medication adherence in DOAC therapy: EDUC-AOD, a case control study
Doctor S. Cohen (Paris, FR)
Abstract Slides
Presentation thumbnail
Adherence to a lifestyle monitoring system in cardiac care: results of the Care-On clinical trial
Ms M. Goevaerts (Eindhoven, NL)
Abstract Slides
Presentation thumbnail
Adherence to phase 3 cardiac rehabilitation: predictors and outcomes
Professor R. Pinto (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
Supporting adherence: status quo and best practice

The Event

Event poster

ESC Preventive Cardiology 2025

3 April - 5 April 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources